MAKO Surgical (Nasdaq: MAKO ) made an appearance at the Piper Jaffray investor conference this week, partially in order to address some investor concerns about why the company needed to raise capital now, and why it decided to tap the equity markets versus using its available credit line with Deerfield Capital Management. In this video, Motley Fool health care analyst Brenton Flynn discusses what MAKO said about those points, and he highlights a few other interesting tidbits from the conference presentation and question-and-answer sessions.
For investors looking to learn more about MAKO Surgical and exactly what makes this stock a buy or a sell, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.